본문 바로가기 주메뉴 바로가기
22대 대한민국 국회 국회정보길라잡이 국회의원검색
회원가입 로그인
HOME

정보검색

소장정보 검색

국회도서관 홈으로 정보검색 소장정보 검색
결과 내 검색 동의어 포함
결과 내 검색 동의어 포함

-

초록보기

Purpose This study aimed to assess the real-world clinical outcomes of consolidative durvalumab in patients with unresectable locally advanced non–small cell lung cancer (LA-NSCLC) and to explore the role of radiotherapy in the era of immunotherapy.

Materials and Methods This retrospective study assessed 171 patients with unresectable LA-NSCLC who underwent concurrent chemoradiotherapy (CCRT) with or without consolidative durvalumab at Asan Medical Center between May 2018 and May 2021. Primary outcomes included freedom from locoregional failure (FFLRF), distant metastasis-free survival (DMFS), progression-free survival (PFS), and overall survival (OS).

Results Durvalumab following CCRT demonstrated a prolonged median PFS of 20.9 months (p=0.048) and a 3-year FFLRF rate of 57.3% (p=0.008), compared to 13.7 months and 38.8%, respectively, with CCRT alone. Furthermore, the incidence of in-field recurrence was significantly greater in the CCRT-alone group compared to the durvalumab group (26.8% vs. 12.4%, p=0.027). While median OS was not reached with durvalumab, it was 35.4 months in patients receiving CCRT alone (p=0.010). Patients positive for programmed cell death ligand 1 (PD-L1) expression showed notably better outcomes, including FFLRF, DMFS, PFS, and OS. Adherence to PACIFIC trial eligibility criteria identified 100 patients (58.5%) as ineligible. The use of durvalumab demonstrated better survival regardless of eligibility criteria.

Conclusion The use of durvalumab consolidation following CCRT significantly enhanced locoregional control and OS in patients with unresectable LA-NSCLC, especially in those with PD-L1–positive tumors, thereby validating the role of durvalumab in standard care.

권호기사

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 목차
HER2-low breast cancer : now and in the future Sora Kang, Sung-Bae Kim p. 700-720

Clinical practice recommendations for the use of next-generation sequencing in patients with solid cancer : a joint report from KSMO and KSP Miso Kim, Hyo Sup Shim, Sheehyun Kim, In Hee Lee, Jihun Kim, Shinkyo Yoon, Hyung-Don Kim, Inkeun Park, Jae Ho Jeong, Changhoon Yoo ... [et al.] p. 721-742

Phase 1/2a study of rivoceranib, a selective VEGFR-2 angiogenesis inhibitor, in patients with advanced solid tumors Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma p. 743-750

Association of immune-related adverse events and the efficacy of anti-PD-(L)1 monotherapy in non-small cell lung cancer : adjusting for immortal-time bias Ying Yu, Ning Chen, Sizhe Yu, Wanji Shen, Wanchen Zhai, Hui Li, Yun Fan p. 751-764

Analytical and clinical validation of a highly sensitive NGS-based ctDNA assay with real-world concordance in non-small cell lung cancer Hanbaek Yi, Jeonghwan Youk, Yoojoo Lim, Hanseong Roh, Dongsoo Kyung, Hwang-Phill Kim, Duhee Bang, Bhumsuk Keam, Tae-Min Kim, Miso Kim, Dong-Wan Kim, Tae-You Kim p. 765-773

Comparison of clinicopathogenomic features and treatment outcomes of EGFR and HER2 Exon 20 insertion mutations in non-small cell lung cancer : single-institution experience So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho Lee p. 774-784

Contribution of enhanced locoregional control to improved overall survival with consolidative durvalumab after concurrent chemoradiotherapy in locally advanced non-small cell lung cancer : insights from real-world data Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim p. 785-794

Trastuzumab Biosimilar (HLX02), pertuzumab plus chemotherapy in patients with HER2-positive metastatic breast cancer after progression of trastuzumab : a prospective, phase Ⅱ study Ruyan Zhang, Xiaoran Liu, Guohong Song, Yan Zhang, Huiping Li p. 795-801

Implementation of BRCA test among young breast cancer patients in South Korea : a nationwide cohort study Yung-Huyn Hwang, Tae-Kyung Yoo, Sae Byul Lee, Jisun Kim, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Il Yong Chung p. 802-808

(The) clinical efficacy of colorectal cancer patients with pulmonary oligometastases by sterotactic body ablative radiotherapy : a meta-analysis Jae-Uk Jeong, Chai Hong Rim, Gyu Sang Yoo, Won Kyung Cho, Eui Kyu Chie, Yong Chan Ahn, Jong Hoon Lee p. 809-824

(The) persistence of hypertriglyceridemia and the risk of early onset colorectal cancer according to tumor subsites : a nationwide population-based study Young Hoon Chang, Cheol Min Shin, Kyungdo Han, Jin Hyung Jung, Eun Hyo Jin, Joo Hyun Lim, Seung Joo Kang, Yoon Jin Choi, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee p. 825-837

Combined high-dose radiotherapy with sequential gemcitabine-cisplatin based chemotherapy increase the resectability and survival in locally advanced unresectable intrahepatic cholangiocarcinoma : a multi-institutional cohort study Jung Ho Im, Jeong Il Yu, Tae Hyun Kim, Tae Gyu Kim, Jun Won Kim, Jinsil Seong p. 838-846

Global expanded access program for pemigatinib in patients with previously treated locally advanced or metastatic cholangiocarcinoma and fibroblast growth factor receptor gene alterations Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft p. 847-855

Invasiveness of upper tract urothelial carcinoma : clinical significance and integrative diagnostic strategy Bokyung Ahn, Doeun Kim, Kye Jin Park, Ja-Min Park, Sun Young Yoon, Bumsik Hong, Yong Mee Cho, Deokhoon Kim p. 856-870

Adjuvant chemotherapy for upper tract urothelial carcinoma : a real-world, retrospective study Junho Lee, Sung Hee Lim, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park p. 871-876

Single early intravesical instillation of epirubicin for preventing bladder recurrence after nephroureterectomy in upper urinary tract urothelial carcinoma Jong Hoon Lee, Chung Un Lee, Jae Hoon Chung, Wan Song, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Hwan Sung p. 877-884

Bilateral seminal vesicle invasion as a strong prognostic indicator in T3b prostate cancer patients following radical prostatectomy : a comprehensive, multicenter, long-term follow-up study Jungyo Suh, In Gab Jeong, Hwang Gyun Jeon, Chang Wook Jeong, Sangchul Lee, Seong Soo Jeon, Seok-Soo Byun, Cheol Kwak, Hanjong Ahn p. 885-892

Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of the bladder : post hoc analysis of two prospective studies Sung Wook Cho, Sung Hee Lim, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park p. 893-897

Predicted cervical cancer prevention : impact of national HPV vaccination program on young women in South Korea Kyeongmin Kwak, Seung-sik Hwang p. 898-908

(The) role of early and delayed surgery for infants with congenital brain tumors Jong Seok Lee, Ji Yeoun Lee, Kyung Hyun Kim, Sung-Hye Park, Eun Jung Koh, Seung-Ki Kim, Ji Hoon Phi p. 909-919

Feasibility of circulating tumor DNA analysis in patients with follicular lymphoma Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim p. 920-935

Secondary malignancies in multiple myeloma in Korean patients : a nationwide population-based study Boyoung Park, Eunyoung Lee, Junghyun Yoon, YoungJu Park, Hyeon-Seok Eom p. 936-944

CD19-specific CAR-T cell treatment of 115 children and young adults with acute B lymphoblastic leukemia : long-term follow-up Yu Wang, Yu-juan Xue, Ying-xi Zuo, Yue-ping Jia, Ai-dong Lu, Hui-min Zeng, Le-ping Zhang p. 945-955

Nation-wide retrospective analysis of allogeneic stem cell transplantation in patients with multiple myeloma : a study from Korean Multiple Myeloma Working Party (KMM1913) Ho-Jin Shin, Do-Young Kim, Kihyun Kim, Chang-Ki Min, Je-Jung Lee, Yeung-Chul Mun, Won-Sik Lee, Sung-Nam Lim, Jin Seok Kim, Joon Ho Moon, Da Jung Kim, Soo-Mee Bang, Jong-Ho Won, Jae-Cheol Jo, Young Il Koh p. 956-966

Molecular and treatment characteristics of SMARCB1 or SMARCA4-deficient undifferentiated tumor : retrospective case series Hyeon Gyu Kang, Jiwon Koh, Tae Min Kim, Doo Hee Han, Tae-Bin Won, Dong-Wan Kim, Dong-Young Kim, Bhumsuk Keam p. 967-971

(Correspondence) Bridging the gap between trial adverse events and real-world data Sang Hyuk Kim, Hyun Lee, Dong Won Park p. 972-973

참고문헌 (29건) : 자료제공( 네이버학술정보 )

참고문헌 목록에 대한 테이블로 번호, 참고문헌, 국회도서관 소장유무로 구성되어 있습니다.
번호 참고문헌 국회도서관 소장유무
1 Cancer Manag Res. 2021 Dec 14;13:9167-9173 미소장
2 N Engl J Med. 2017 Nov 16;377(20):1919-1929 미소장
3 Cancers (Basel). 2021 Mar 31;13(7): 미소장
4 JAMA. 2023 Apr 25;329(16):1352-1353 미소장
5 Trends Cancer. 2016 Jun;2(6):286-294 미소장
6 Radiat Oncol. 2021 Dec 4;16(1):231 미소장
7 Contemp Oncol (Pozn). 2021;25(1):45-52 미소장
8 Cancer Res Treat. 2023 Apr;55(2):400-407 미소장
9 Aging (Albany NY). 2015 Mar;7(3):144-5 미소장
10 Cancer Res Treat. 2021 Oct;53(4):1033-1041 미소장
11 BMC Cancer. 2022 Apr 4;22(1):364 미소장
12 Radiother Oncol. 2021 Jul;160:266-272 미소장
13 J Thorac Oncol. 2023 Feb;18(2):181-193 미소장
14 J Thorac Oncol. 2023 Aug;18(8):1042-1054 미소장
15 Thorac Cancer. 2020 May;11(5):1280-1287 미소장
16 J Thorac Oncol. 2023 Jan;18(1):e1-e2 미소장
17 J Clin Invest. 2013 Jul;123(7):2756-63 미소장
18 World J Clin Oncol. 2020 Nov 24;11(11):898-917 미소장
19 Radiat Oncol. 2022 Jan 15;17(1):7 미소장
20 Eur J Cancer. 2021 Jan;142:83-91 미소장
21 Lung Cancer. 2020 Aug;146:23-29 미소장
22 J Clin Oncol. 2022 Apr 20;40(12):1301-1311 미소장
23 Immunotherapy. 2022 Aug;14(12):927-944 미소장
24 Thorac Cancer. 2021 Jan;12(2):245-250 미소장
25 Transl Lung Cancer Res. 2021 Jan;10(1):506-518 미소장
26 J Thorac Oncol. 2021 May;16(5):860-867 미소장
27 Invest New Drugs. 2021 Aug;39(4):1189-1196 미소장
28 J Natl Compr Canc Netw. 2023 Apr;21(4):340-350 미소장
29 Cancer Immunol Res. 2015 Jun;3(6):610-9 미소장

추천서가 (다양한 추천 자료를 만나보세요)

권호기사보기

권호기사 목록 테이블로 기사명, 저자명, 페이지, 원문, 기사목차 순으로 되어있습니다.
기사명 저자명 페이지 원문 기사목차